Table 2.
D 10 |
D 14 |
D 18 |
|||||||
---|---|---|---|---|---|---|---|---|---|
Gene | Control | LR | LP | Control | LR | LP | Control | LR | LP |
MYF5 | 1 ± 0.03a | −8.33 ± 0.41b | −6.66 ± 0.33c | 1.0 ± 0.28a | −7.14 ± 0.35b | −3.44± 0.17c | 1.0 ± .05a | 1.44 ± 0.07b | 1.56 ± 0.07c |
MYOD | 1 ± 0.07a | −2.56 ± 0.12b | −2.12 ± 0.10c | 1.0 ± 0.14a | −2.5 ± 0.12b | −1.96 ± 0.09c | 1.0 ± 0.06a | 1.98 ± 0.09b | −1.16 ± 0.05a |
MYOG | 1 ± 0.04a | −2.5 ± 0.125b | −1.58± 0.07b | 1.0 ± 0.11a | 1.00 ± 0.05a | −1.16± 0.05a | 1.0 ± 0.08a | 1.37 ± 0.06b | 4.37 ± 0.21c |
MRF4 | 1 ± 0.15a | −2.43 ± 0.12b | −1.75 ± 0.08b | 1.0 ± 0.19a | −2.94 ± 0.14b | −2.04 ± 0.10c | 1.0 ± 0.16a | 1.47 ± 0.07b | −3.33 ± 0.16c |
IGF1 | 1.0 ± 0.25a | 1.43 ± 0.07b | 3.04 ± 0.15c | 1.0 ± 0.21a | 1.35 ± 0.06b | 1.34 ± 0.06b | 1.0 ± 0.27a | 1.61 ± 0.08b | 1.14 ± 0.05a |
IGF1R | 1.0 ± 0.13a | 2.73 ± 0.13b | 2.18 ± 0.10c | 1.0 ± 0.16a | −1.63 ± 0.08b | −1.13 ± 0.05a | 1.0 ± 0.15a | 3.60 ± 0.18b | −1.09 ± 0.05a |
FGF2 | 1.0 ± 0.22a | −1.02 ± 0.05a | 1.02 ± 0.05a | 1.0 ± 0.34a | −1.29 ± 0.06a | 1.27 ± 0.12a | 1.0 ± 0.27a | 2.56 ± 0.10b | 2.17 ± 0.13c |
FGF4 | 1.0 ± 0.28a | 1.15 ± 0.05a | 1.74 ± 0.08b | 1.0 ± 0.37a | −1.12 ± 0.05a | −1.63 ± 0.08b | 1.0 ± 0.32a | 3.53 ± 0.17b | 3.64 ± 0.18b |
Data are expressed as mean ± SEM.
Different superscripts indicate significant difference in relative gene expression between control (a) and treatments within each day at P < 0.05.
Abbreviations: LP, Lactobacillus paracasei; LR, Lactobacillus rhamnosus.